GSK stock holds near 52-week high after Jefferies signal

Published on 09/19/2026 at 11:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GSK stock closed at USD 51.06 on September 17, 2026, up 1.53 percent. Yahoo Finance also shows a market cap of USD 102.263 billion and a 52-week range of USD 39.29 to USD 61.70.

Moderne Pharma-Produktionsanlage mit Glasfassade und Laboren bei Dämmerlicht — GSK plc (ISIN GB0009252882) betreibt moderne Pharmaanlagen mit Laboren und Produktionshallen in der Abenddämmerung, Illustration mit AI erstellt.

GSK plc stock (ISIN GB0009252882) closed at USD 51.06 on September 17, 2026, up 1.53 percent, with a market value of USD 102.263 billion and a 52-week range of USD 39.29 to USD 61.70.

Deutsche Bank stays cautious

According to finanzen.at, Deutsche Bank kept GSK at Hold on September 18, 2026. The same overview shows GSK alongside a separate Barclays downgrade dated January 6, 2026, but the visible recent call for investors is the Hold view on GSK.

Yahoo Finance shows a previous close of USD 50.29, a day range of USD 50.62 to USD 51.08 and volume of 3,071,065 shares on the September 17 close.

Revenue and earnings stay solid

Yahoo Finance lists GSK revenue at USD 33.2 billion on a trailing-12-month basis, net income attributable to common shareholders at USD 4.82 billion and diluted EPS at 3.15. It also shows Q2 FY26 revenue of USD 8.41 billion, earnings of USD 435 million and a profit margin of 5.17 percent.

For comparison, Yahoo Finance shows Q2 FY26 EPS at 1.34 against an estimate of 1.25, a beat of 0.09, while the trailing 12-month margin stands at 14.52 percent. That gives the stock a valuation backdrop that is more stable than the day-to-day price move.

Stock near the high end

GSK stock ended September 17, 2026 at USD 51.06, about 17.3 percent below the 52-week high of USD 61.70 and 29.7 percent above the 52-week low of USD 39.29.